Which regulatory agency oversees the approval of chemotherapy drugs in the U.S.?

The Food and Drug Administration (FDA) is the regulatory agency responsible for overseeing the approval of chemotherapy drugs in the United States. The FDA evaluates new medications and treatments to ensure they are safe and effective for public use before they can be marketed and prescribed by healthcare providers. This process involves rigorous clinical trials and a thorough review of the drug's manufacturing, safety, efficacy, and labeling.

The other agencies mentioned have different roles. The Centers for Disease Control and Prevention (CDC) primarily focuses on public health and disease prevention, not drug approval. The National Institutes of Health (NIH) is involved in biomedical research and does not regulate drug approval, although it may fund studies related to drug therapies. The Environmental Protection Agency (EPA) mainly deals with environmental protection and regulations concerning pollutants and hazardous substances, rather than directly overseeing medication approval.